Salvatore Calabrese

Insider Reports History

Entity
Individual
Location
C/O Gain Therapeutics, Inc., 4800 Hampden Lane, Suite 200, Bethesda, MD
Signature
/s/ Jason Minio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Salvatore Calabrese:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gain Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 50K $293K $5.86 Mar 23, 2023 Direct
Gain Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 25K $62.5K $2.50 Mar 23, 2023 Direct
Gain Therapeutics, Inc. Chief Financial Officer Common Stock 3K $7.38K $2.46 May 19, 2022 Direct

Insider Reports Filed by Salvatore Calabrese

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GANX Gain Therapeutics, Inc. Mar 23, 2023 2 $0 4 Mar 27, 2023 Chief Financial Officer
GANX Gain Therapeutics, Inc. Jul 15, 2022 2 $0 4 Jul 19, 2022 Chief Financial Officer
GANX Gain Therapeutics, Inc. May 19, 2022 1 $8.1K 4/A May 23, 2022 CHIEF FINANCIAL OFFICER